Cargando…
Clinical utility of fixed combinations of sitagliptin–metformin in treatment of type 2 diabetes
Adequate glycemic control in type 2 diabetes remains a difficult but achievable goal. The development of new classes of glucose-lowering medications, including in particular the incretin-based therapies, provides an opportunity to utilize combinations of medications which target multiple physiologic...
| Autores principales: | , , |
|---|---|
| Formato: | Texto |
| Lenguaje: | English |
| Publicado: |
Dove Medical Press
2010
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3047989/ https://www.ncbi.nlm.nih.gov/pubmed/21437106 http://dx.doi.org/10.2147/DMSOTT.S10195 |